FDA authorizes Moderna COVID-19 vaccine for emergency use
By Matthew Perrone and Lauran Neergaard
Published
FDA advisory committee votes to recommend emergency use of Moderna COVID-19 vaccine
A key advisory committee to the FDA on Thursday voted to recommend the approval of Moderna’s COVID-19 vaccine for emergency use, one of the final hurdles before FDA authorization.
WASHINGTON - The U.S. Food and Drug Administration authorized Moderna’s coronavirus vaccine for emergency use on Friday, the second vaccine to be approved by U.S. regulators to prevent severe COVID-19 illness.
FDA Commissioner Stephen M. Hahn, called the approval another crucial step in the fight against this global pandemic.
2nd COVID-19 vaccine set for OK in US with panel endorsement wmal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wmal.com Daily Mail and Mail on Sunday newspapers.
By Press Association 2021
Nurse Kathe Olmstead, right, gives a volunteer an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna
The head of the Food and Drug Administration (FDA) has said his agency will move to quickly authorise a second Covid-19 vaccine for the US to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
FDA commissioner Stephen Hahn said in a statement that regulators have communicated their plans to pharmaceutical company Moderna, which co-developed the vaccine with the National Institutes of Health.
The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18-years-old and up.
FDA expected to greenlight Moderna s COVID-19 vaccine: HHS Secretary Alex Azar 6abc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 6abc.com Daily Mail and Mail on Sunday newspapers.
FDA plans to OK 2nd COVID-19 vaccine after panel endorsement
By MATTHEW PERRONE and LAURAN NEERGAARDDecember 18, 2020 GMT
WASHINGTON (AP) The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up.